Back to top
more

Cigna Corporation (CI)

(Delayed Data from NYSE)

$188.92 USD

188.92
2,563,696

-2.84 (-1.48%)

Updated Feb 26, 2020 03:59 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.47%
17.86%
9.49%
5.20%
2.00%
10.75%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

B Value | A Growth | B Momentum | A VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Sheraz Mian

Earnings Season Scorecard and Analyst Reports for Mastercard, Comcast & Others

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Comcast (CMCSA) and Honeywell International (HON).

QCOM MA HON D CSCO CMCSA CI

Zacks Equity Research

Company News for Feb 7, 2020

Companies in the news are: BMY, CI, NOK, CAH

BMY NOK CI CAH

Zacks Equity Research

Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?

Is (CI) Outperforming Other Finance Stocks This Year?

CI

Zacks Equity Research

Cigna (CI) Q4 Earnings and Revenues Beat Estimates, Rise Y/Y

Cigna (CI) Q4 results reflect revenue and membership growth on the back of Express Scripts acquisition.

CI HUM UNH CNC

Zacks Equity Research

Cigna (CI) to Report Q4 Earnings: What's in the Offing?

Cigna's (CI) earnings performance is likely to have gained from the accretive Express Scripts acquisition.

CI HUM MOH TDOC

Zacks Equity Research

Cigna (CI) Earnings Expected to Grow: Should You Buy?

Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CI

Zacks Equity Research

Here's Why You Should Add BioDelivery Stock to Your Portfolio

Here are five reasons which make BioDelivery (BDSI)) a good investment option in 2020.

PFE CI BDSI ENDP

Sheraz Mian

Q4 Earnings Scorecard and Research Reports on Netflix, Chevron & Others

Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), Netflix (NFLX) and NextEra Energy (NEE).

NFLX NEE IBM HCA CVX CI

Madeleine Johnson

Healthcare in Retirement: Personal Finance 101

Like all retirement-related things, healthcare is very important to plan for (financially and emotionally). Here's what retirees need to know about healthcare in your nest egg years.

CI ANTM UNH

Tirthankar Chakraborty

Top Stocks to Invest in America's Aging Workforce

Percentage of Americans aged 65 and above will climb to 21% by 2030 from 15% in 2018. In fact, the number of Americans aged more than 60 have already tripled since 1950.

GOOGL AAPL CI MDT

Zacks Equity Research

Why is Hold Strategy Appropriate for CNO Financial (CNO) Now?

Riding high on its growing top line, reducing costs and an impressive capital position, CNO Financial (CNO) is well placed to benefit its investors.

MET CI CNO MTG

Zacks Equity Research

UnitedHealth (UNH) Q4 Earnings Beat on Revenue Growth

UnitedHealth's (UNH) Q4 results reflect strong contribution from its health benefits and service segments.

CI WCG UNH JYNT

Zacks Equity Research

Top Ranked Growth Stocks to Buy for January 15th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 15th

FOCS DAL CI BLD

Zacks Equity Research

Cigna, Oscar Team Up to Offer Health Aids to Small Businesses

Cigna (CI) partners with Oscar to provide health solutions for small businesses.

CI ANTM WCG UNH

Sapna Bagaria

Cigna Lags Industry in '19: Can Efforts Aid Recovery in 2020?

Cigna's (CI) business streamlining and acquisitions are expected to drive growth in 2020.

CI HUM UNH ANTM

Zacks Equity Research

The Zacks Analyst Blog Highlights: SAP, AbbVie, Sinopec, Cigna and Intuitive Surgical

The Zacks Analyst Blog Highlights: SAP, AbbVie, Sinopec, Cigna and Intuitive Surgical

SNP ABBV SAP CI ISRG

Mark Vickery

Top Stock Reports for SAP, AbbVie & Sinopec

Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), AbbVie (ABBV) and Sinopec (SNP).

SNP SAP LLY ISRG CI ABBV

Zacks Equity Research

Cigna to Divest Non-Health Unit, Streamline Operations

Cigna (CI) announces sale of its Group Life and Disability business to focus on debt reduction and core business of healthcare.

CI SEM WCG AMED

Zacks Equity Research

WellCare Health, Fitbit Collaborate to Aid Diabetes Patients

WellCare Health (WCG) and Fitbit team up to encourage Georgia-based WellCare Medicaid members to manage their diabetic condition.

FIT CI ANTM WCG

Sapna Bagaria

HMO Industry Outlook: Multiple Levers to Drive Growth

Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.

WCG SEM MOH CVS CI ANTM

Zacks Equity Research

Cigna Considers Divesting Its Non-Health Insurance Business

Speculations ran rife that Cigna (CI) is on the lookout of a bidder for its non-health insurance arm to streamline in-house operations.

LNC SLF CI MET

Sapna Bagaria

UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services

UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.

CI UNH HUM CVS

Sapna Bagaria

Here's Why Select Medical (SEM) Stock Looks Attractive

Select Medical (SEM) benefits from revenue growth, acquisitions, and strong earnings guidance.

CI ANTM SEM HUM

Sapna Bagaria

UnitedHealth (UNH) Provides Guidance for 2020, Shares Fall

UnitedHealth's (UNH) guidance for 2020 indicates revenue and earnings growth but it is believed to be conservative, leading to a decline in shares.

CI ANTM HUM UNH

Zacks Equity Research

BioDelivery's Belbuca Sales & Symproic Addition Encouraging

BioDelivery's (BDSI) efforts to increase preferred coverage for Belbuca and the acquisition of the rights to Symproic are likely to help continue its momentum.

CI BDSI ALKS ENDP